Literature DB >> 3407684

Magnesium plus nifedipine: potentiation of hypotensive effect in preeclampsia?

G D Waisman1, L M Mayorga, M I Cámera, C A Vignolo, A Martinotti.   

Abstract

Two women with preeclampsia treated unsuccessfully with alpha-methyldopa and magnesium sulfate became profoundly hypotensive when oral nifedipine was added. Blood pressure returned to previous levels without changes in fetal vitality. Awareness of this potentiation is important because nifedipine is being used increasingly in the treatment of pregnancy-related hypertension.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3407684     DOI: 10.1016/s0002-9378(88)80072-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  13 in total

1.  Management of preterm labour. Nifedipine in management of preterm labour is safe.

Authors:  D N Papatsonis; H P van Geijn; G A Dekker
Journal:  BMJ       Date:  1999-07-24

Review 2.  Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy.

Authors:  P M Kyle; C W Redman
Journal:  Drug Saf       Date:  1992 May-Jun       Impact factor: 5.606

Review 3.  Determinants of neonatal blood pressure.

Authors:  Alison L Kent; Tejasvi Chaudhari
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

Review 4.  Preeclampsia. Still an enigma.

Authors:  J Duda
Journal:  West J Med       Date:  1996-04

Review 5.  Role of magnesium sulfate in seizure prevention in patients with eclampsia and pre-eclampsia.

Authors:  J Anthony; R B Johanson; L Duley
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

Review 6.  Calcium antagonists. Drug interactions of clinical significance.

Authors:  T Rosenthal; D Ezra
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

7.  Modern management of eclampsia.

Authors:  O Salha; J J Walker
Journal:  Postgrad Med J       Date:  1999-02       Impact factor: 2.401

Review 8.  Treating hypertension in women of child-bearing age and during pregnancy.

Authors:  L A Magee
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 9.  Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy.

Authors:  E Rey; J LeLorier; E Burgess; I R Lange; L Leduc
Journal:  CMAJ       Date:  1997-11-01       Impact factor: 8.262

10.  Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis.

Authors:  Laura A Magee; Chris Cham; Elizabeth J Waterman; Arne Ohlsson; Peter von Dadelszen
Journal:  BMJ       Date:  2003-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.